Eupraxia Pharmaceuticals Inc. EPRX
8.01
(0.15)
(1.84%)
as of 25 Sep
- Market cap
- $537.8M
- P/E
- 0.0×
Follow EPRX
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
6.08 | 1.02 | 11.10 | 15.12 |
Net Debt/EBITDA |
0.53 | 0.32 | 1.23 | 2.11 |
Debt/Assets |
46.73% | 51.31% | 0.00% | 0.09% |
Debt/Equity |
1.24 | 11.65 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.78 | 0.74 | 1.16 | 0.69 |
Capex/Depreciation |
(1.59) | (0.47) | (0.44) | (2.48) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | (696.79%) | (5,054.21%) | (161.71%) | |
| 0.00% | (143.29%) | (93.93%) | (67.89%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(115.75%) | (3,364.43%) | (81.81%) | (51.19%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.76) | (0.86) | (0.89) | (0.73) |
Cash per Share |
0.95 | 0.80 | 0.98 | 2.02 |
Shareholders Equity per Share |
0.37 | 0.04 | 0.94 | 2.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.37 | 0.04 | 0.94 | 2.01 |
Free Cash Flow |
(14.63) | (20.82) | (30.07) | (29.14) |
Working Capital |
15.53 | 0.43 | 31.33 | 79.47 |
Capital Expenditures |
(0.24) | (0.07) | (0.08) | (0.59) |
Net Current Asset Value |
6.67 | 0.43 | 31.33 | 79.39 |
| Other line items | ||||
Quick Ratio |
6.00 | 1.01 | 10.74 | 14.43 |
Depreciation/Fixed assets |
0.33 | 0.38 | 0.48 | 0.28 |
Cash ROIC |
(43.13%) | (69.07%) | (46.74%) | (18.24%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.75) | (0.86) | (0.88) | (0.71) |
Capex per Share |
(0.01) | 0.00 | 0.00 | (0.01) |
Average Receivables |
— | 0.14 | 0.21 | 0.45 |
Average Payables |
— | 3.43 | 3.48 | 4.29 |
Average Assets |
— | 19.69 | 27.60 | 60.55 |
Average Common Equity |
— | 4.05 | 0.51 | 25.42 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates